CAPRICOR THERAPEUTICS, INC. (CAPR) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2025-12-31..
Gross margin
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 0.00 USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2025-12-31 | (m) | $0.00 | (m) | (m) |
| 2024-12-31 | (m) | $22.27M | (m) | (m) |
| 2024-09-30 | (m) | $23.23M | (m) | (m) |
| 2024-06-30 | (m) | $27.15M | (m) | (m) |
| 2024-03-31 | (m) | $27.10M | (m) | (m) |
| 2023-12-31 | (m) | $25.18M | (m) | (m) |
| 2023-09-30 | (m) | $14.05M | (m) | (m) |
| 2023-06-30 | (m) | $9.46M | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $2.55M | (m) | (m) |
| 2022-09-30 | (m) | $1.59M | (m) | (m) |
| 2021-12-31 | (m) | $244.90K | (m) | (m) |
| 2021-09-30 | (m) | $302.73K | (m) | (m) |
| 2021-06-30 | (m) | $319.59K | (m) | (m) |
| 2021-03-31 | (m) | $165.37K | (m) | (m) |
| 2020-12-31 | (m) | $310.25K | (m) | (m) |
| 2020-09-30 | (m) | $474.52K | (m) | (m) |
| 2020-06-30 | (m) | $599.73K | (m) | (m) |
| 2020-03-31 | (m) | $960.22K | (m) | (m) |
| 2019-12-31 | (m) | $1.01M | (m) | (m) |
| 2019-09-30 | (m) | $1.43M | (m) | (m) |
| 2019-06-30 | (m) | $1.51M | (m) | (m) |
| 2019-03-31 | (m) | $1.50M | (m) | (m) |
| 2018-12-31 | (m) | $1.67M | (m) | (m) |
| 2018-09-30 | (m) | $1.50M | (m) | (m) |
| 2018-06-30 | (m) | $1.59M | (m) | (m) |
| 2018-03-31 | (m) | $2.19M | (m) | (m) |
| 2017-12-31 | (m) | $2.67M | (m) | (m) |
| 2017-09-30 | (m) | $3.10M | (m) | (m) |
| 2017-06-30 | (m) | $3.53M | (m) | (m) |
| 2017-03-31 | (m) | $3.66M | (m) | (m) |
| 2016-12-31 | (m) | $4.00M | (m) | (m) |
| 2016-09-30 | (m) | $4.22M | (m) | (m) |
| 2016-06-30 | (m) | $4.78M | (m) | (m) |
| 2016-03-31 | (m) | $4.94M | (m) | (m) |
| 2015-12-31 | (m) | $5.52M | (m) | (m) |
| 2015-09-30 | (m) | $5.80M | (m) | (m) |
| 2015-06-30 | (m) | $5.78M | (m) | (m) |
| 2015-03-31 | (m) | $5.53M | (m) | (m) |
| 2014-12-31 | (m) | $4.79M | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $503.23K | (m) | (m) |
| 2013-09-30 | (m) | $0.00 | (m) | (m) |
| 2013-06-30 | (m) | $0.00 | (m) | (m) |
| 2013-03-31 | (m) | $0.00 | (m) | (m) |
| 2012-12-31 | (m) | $195.50K | (m) | (m) |
| 2012-09-30 | (m) | $391.00K | (m) | (m) |
| 2012-06-30 | (m) | $1.20M | (m) | (m) |
| 2012-03-31 | (m) | $1.55M | (m) | (m) |
| 2011-12-31 | (m) | $1.35M | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |